Showing results (161-170 of 207) with videos related to

Sort By:
Pageof 21
Journal of Proteome Research|March 20, 2012
Peroxiredoxins 3 and 4 are overexpressed in prostate cancer tissue and affect the proliferation of prostate cancer cells in vitroRamesh Ummanni, Frederico Barreto, Simone Venz, et al.
Cancers|February 11, 2023
COVID and Cancer: A Complete 3D Advanced Radiological CT-Based Analysis to Predict the OutcomeSyed Rahmanuddin, Asma Jamil, Ammar Chaudhry, et al.
Journal for Immunotherapy of Cancer|June 21, 2022
Spartalizumab or placebo in combination with dabrafenib and trametinib in patients with BRAF V600-mutant melanoma: exploratory biomarker analyses from a randomized phase 3 trial (COMBI-i)Hussein A Tawbi, Caroline Robert, Jan C Brase, et al.
BMC Cancer|December 7, 2011
TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signalingJan C Brase, Marc Johannes, Heiko Mannsperger, et al.
Critical Care Medicine|May 25, 2001
Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES StudyK Reinhart, T Menges, B Gardlund, et al.
Clinics (Sao Paulo, Brazil)|May 16, 2012
Head and neck paragangliomas: clinical and molecular genetic classificationChristian Offergeld, Christoph Brase, Svetlana Yaremchuk, et al.
Clinical Medicine (London, England)|March 18, 2026
Clinical Predictors of Malignancy in Lymphadenopathy: A Multivariable Analysis from a Quick Diagnosis UnitEloi Garcia-Vives, Jaime Rodriguez-Morera, Ariadna Brase Arnau, et al.
Optics Letters|October 2, 2009
Demonstration of x-ray microscopy with an x-ray laser operating near the carbon K edgeL B Da Silva, J E Trebes, S Mrowka, et al.
British Journal of Cancer|October 20, 2012
Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancerS Darb-Esfahani, R Kronenwett, G von Minckwitz, et al.
RSC Medicinal Chemistry|July 14, 2025
Design, synthesis, and apoptotic antiproliferative efficacy of new quinazoline/1,3,4-oxadiazole-2-thione derived EGFR/HER-2 dual inhibitors with anti-breast cancer activityHesham A M Gomaa, Mohamed E Shaker, Sami I Alzarea, et al.
Pageof 21